There have been numerous presentations and publications on our technology and on compounds developed using it. Publications related to compounds with our technology include:

IMMUNOGEN COMPOUNDS

Mirvetuximab Soravtansine (IMGN853)


Coltuximab Ravtansine (SAR3419)


IMGN529


IMGN779


IMGN632


PARTNER COMPOUNDS

Kadcyla


SAR650984


BT-062


Anetumab Ravtansine (BAY 94-9343)


SAR566658


You are now leaving this website. If you would like to continue, click Continue.
CancelContinue